AI assistant
Anterix Inc. — Director's Dealing 2025
Jan 14, 2025
33018_dirs_2025-01-14_ab5d0e64-b358-4e0a-84ac-339946c5dd50.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2024-12-26
Reporting Person: Kuhn Thomas R. (Director, Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-26 | Stock Option (Right to Buy) | $31.25 | A | 7108 | Acquired | 2034-12-26 | Common Stock (7108) | Direct |
Footnotes
F1: This amended Form 4 is being filed to correct the previously reported grant amount of 61,804 option shares to the Reporting Person to reflect an actual grant of 7,108 option shares. The previously reported amount exceeded the compensation limit for non-employee directors set forth in the Issuer's 2023 Stock Plan by 54,696 option shares (the "Excess Option Shares"). The grant of the Excess Option Shares was null and void and has been rescinded by the Issuer.
F2: The option shares vest in full on December 26, 2027, subject to the Reporting Person's continued service with the Issuer through this date.